XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current Assets:    
Cash and cash equivalents $ 39,050,832 $ 39,067,236
Short-term investments 9,003,215 24,014,305
Accounts receivable 2,272,373 1,034,492
Inventories 7,992,961 6,461,051
Deferred costs 1,689,497 375,773
Prepaid expenses and other current assets 929,141 1,706,678
Total current assets 60,938,019 72,659,535
Equipment, molds, furniture and fixtures, net 9,668,417 6,952,251
Patent rights, net 2,960,864 1,345,177
Goodwill 1,095,355 1,095,355
Long-term investments    6,008,169
Other assets 871,168 871,444
Total Assets 75,533,823 88,931,931
Current Liabilities:    
Accounts payable 8,030,911 6,378,712
Accrued expenses and other liabilities 5,980,708 5,453,075
Deferred revenue 6,891,503 4,531,220
Total current liabilities 20,903,122 16,363,007
Deferred revenue - long term 4,225,568 1,855,196
Total liabilities 25,128,690 18,218,203
Stockholders' Equity:    
Preferred Stock: $0.01 par, authorized 3,000,000 shares, none outstanding      
Common Stock: $0.01 par; authorized 200,000,000 shares; 131,592,798 and 128,740,604 issued and outstanding at September 30, 2014 and December 31, 2013, respectively 1,315,928 1,287,406
Additional paid-in capital 248,149,323 243,375,465
Accumulated deficit (198,374,712) (173,295,941)
Accumulated other comprehensive loss (685,406) (653,202)
Total Stockholders' Equity 50,405,133 70,713,728
Total Liabilities and Stockholders' Equity $ 75,533,823 $ 88,931,931